2. UroToday Home
  3. Video Lectures

PCF 2022

Predicting Treatment Response in Prostate Cancer: The Power of Spatial Proteomic Approaches - Christina Curtis
July 10, 2023
Details
Understanding the Potential and Challenges of Sipuleucel-T and Radium-223 in the Management of Metastatic Castration-Resistant Prostate Cancer - Sumit Subudhi
July 7, 2023
Details
Dissecting the Dynamics of the Tumor Microenvironment: Nutrient Availability and Treatment Outcomes - Asmaa El-Kenawi
April 11, 2023
Details
DLL3 Targeting Bispecifics: A New Hope for Tough-to-Treat Prostate Cancer Patients - Rahul Aggarwal
March 6, 2023
Details
The Benefit to Radium-223 Added to Cabozantinib for Patients With Renal Cell Carcinoma With Bone Metastasis, RadiCaL - Rana McKay
March 4, 2023
Details
A Historical Perspective on Radioligand Therapy and Novel Treatment Modalities in the Management of mCRPC - Neil H. Bander
February 6, 2023
Details
Unveiling the Clinical Potential of ctDNA: Implications for Prostate Cancer Management - Neeraj Agarwal
January 31, 2023
Details
The Support and Momentum of the Prostate Cancer Foundation on Prostate Cancer Research and Treatment - Edwin Posadas
January 25, 2023
Details
Immune System Biology of Androgen and AR Functions in T cells in Prostate Cancer - Amy Moran
January 25, 2023
Details
The Impact of Molecular and Genomic Factors on Prostate Cancer Disease Etiology and Health Disparities and The State of Science on Diet and Lifestyle - Lorelei Mucci
January 24, 2023
Details
Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer, Advances and Barriers – Cora Sternberg
January 23, 2023
Details
Rucaparib for Patients with Metastatic Castration-Resistant Prostate Cancer in the TRITON3 Trial – Oliver Sartor
January 23, 2023
Details
From Active Surveillance to Novel Biomarkers: A Seamless Approach to Prostate Cancer Research - Jeff Tosoian
January 17, 2023
Details
From Blood to Diagnosis: the Role of ctDNA in Prostate Cancer Treatment - Alexander Wyatt
January 11, 2023
Details
Targeting Tumor Marker B7-H3 with Engineered Natural Killer Cells - Nicholas Zorko
January 11, 2023
Details
Convergent Therapeutics, Inc. Next Generation Radiopharmaceutical Therapies for Prostate - Philip Kantoff
January 10, 2023
Details
Engineered Cell Therapies for Metastatic Castrate-Resistant Prostate Cancer - Saul Priceman
January 10, 2023
Details
Heterogeneity in Multifocal Prostate Cancer - Simpa Salami
January 10, 2023
Details
Rucaparib Monotherapy Improves Radiographic Progression-Free Survival in Patients With Metastatic Castration-Resistant Prostate Cancer: TRITON3 Trial - Alan Bryce
December 20, 2022
Details
Biological Difference Based on Race: Disparities Throughout the Spectrum of Prostate Cancer - Kosj Yamoah
December 20, 2022
Details
Disparities in Prostate Cancer: Barriers to Access to Clinical Trials - Elisabeth Heath
December 20, 2022
Details
Bipolar Androgen Therapy in the Management of Prostate Cancer - Samuel Denmeade
December 13, 2022
Details
Developing a Blood-Based Biomarker Platform to Predict Treatment Outcomes in Prostate Cancer Patients - Martin Sjöström
December 12, 2022
Details
Biomarker Analysis to Identify Molecular Signatures Predictive of Response in the COMBAT Study - Emmanuel Antonarakis
December 5, 2022
Details
Using Liquid Biopsies in Clinical Practice to Inform Decision Making for Prostate Cancer Care - Joshua Lang
November 30, 2022
Details
Veterans Affair Care Program, Prostate Cancer Biorepository - Isla P. Garraway
November 30, 2022
Details
Exploring the Potential of Lutetium PSMA in High-Risk Localized Prostate Cancer: The LuTectomy Trial - Renu Eapen
November 23, 2022
Details
Addressing Prostate Cancer Health Disparities - Leanne Woods-Burnham
November 22, 2022
Details
Contact-02: A Phase III Trial Shaping the Future of Metastatic Prostate Cancer Care - Neeraj Agarwal
November 22, 2022
Details
Longitudinal Patient Sampling and Immune Profiling in Oligometastatic Prostate Cancer - Sophia Kamran
November 18, 2022
Details
Scaling Up Point-of-Care Genetic Testing in the VA: A Nurse-Led Initiative - Kara Maxwell
November 18, 2022
Details
Exploring the PROSPER Study: A Neoadjuvant Approach to Kidney Cancer - Mohamad Allaf
November 17, 2022
Details
The AFT-19 Study: A Comprehensive Look at High-Risk Prostate Cancer Treatment - Rahul Aggarwal
November 17, 2022
Details
Exploring the Nuances of the PRONOUNCE Trial - Celestia Higano
November 15, 2022
Details
Navigating the Challenges of Somatic Mutation Testing in Prostate Cancer - Joaquin Mateo
November 9, 2022
Details
A Journey Through Prostate Cancer Research: Perspective on the Prostate Cancer Foundation's Impact - Philip Kantoff
November 8, 2022
Details